Ann: Sunrise Bore - field program commences (updated)-LCY.AX, page-27

First 27 Last

Share
Profile

Follow
KLal

81 Posts.

04/06/16

16:39

Post #: 17952483
Share

Originally posted by johnnydust ↑

Totally agree, I purchased as a direct result of Sharon Heng's price sensitive announcement of the $200m funding agreement with NMDC and spiel about the company now being an NMDC group company and their imminent purchase of assets from Atlas, Minemakers etc all of which were false and there was absolutely no mention of the 200 million after this announcement even in the next quarterly which was only a week or two later. There were numerous other announcements which proved to be nothing more than talk but there has been no clarification on them by the company and also no disclosure to shareholders as to why Heng was axed and why she had to pay back funds.

I sent MB an email with words to this effect but haven't heard back from them yet, I do think though that Legacy and NMDC have a case to answer and it would definitely be something worthy of a class action. It needs to be financially beneficial to MB though and they would only take it on if they had enough shareholders with enough holdings where they could make enough of a cut out of potential proceeds. To be honest at this stage its not as much about the money for me as making people accountable for their actions and the results of their actions which hasn't occurred here..

Expand

Fully agree. Being a subsidiary of NMDC with billions of dollar in cash, i guess it should be worthwhile for MB to push class action on fraud or deceptive behaviour announcements.

LCY Price at posting: 0.7¢ Sentiment: Sell Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

There are more pages in this discussion • 15 more messages in this thread...

First 27 Last

Add LCY (ASX) to my watchlist

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $100.2M

Open	High	Low	Value	Volume
1.1¢	1.1¢	1.1¢	$5.096K	463.2K

Buyers (Bids)

No.	Vol.	Price($)
2	40680	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.1¢	1137379	2

View Market Depth

No.	Vol.	Price($)
2	440012	0.003
12	10561995	0.002
10	18900000	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	3287250	5
0.005	2283158	4
0.006	1326530	5
0.007	890736	3
0.008	519875	3

Last trade - 12.04pm 29/11/2024 (20 minute delay)

LCY (ASX) Chart

Ann: Sunrise Bore - field program commences (updated)-LCY.AX, page-27

Top Stories

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

Chimeric clocks $4.17M R&D tax rebate from Canberra

Buyers (Bids)

Sellers (Offers)